StonvexLoading…
StonvexStonvexStonvexCore line items from ENLT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $488.60M | $377.94M | $255.70M | $192.17M |
Operating Income | $332.18M | $175.53M | $158.14M | $90.61M |
Net Income | $160.70M | $66.50M | $98.04M | $38.11M |
EPS (Diluted) | $1.00 | $0.36 | $0.57 | $0.25 |
Total Assets | $8.63B | $5.55B | $4.63B | $3.53B |
Total Liabilities | $6.63B | $4.11B | $3.20B | $2.48B |
Cash & Equivalents | $528.50M | $387.43M | $403.81M | $193.87M |
Free Cash Flow OCF − CapEx | $-1.53B | $-643.98M | $-539.38M | $-565.77M |
Shares Outstanding | Not available | Not available | Not available | Not available |